Cision PR Newswire

Kazia Therapeutics Reports Preclinical Data Showing Paxalisib Reprograms Immunotherapy-Resistant MSS/pMMR Colorectal Cancer and Enhances Response to Immunotherapy

Paxalisib Monotherapy Significantly Reduced Tumor Burden in Pre-Clinical Model of MSS/pMMR Colorectal Cancer, With the Addition of Pembrolizumab Driving a Further Reduction Paxalisib Was...

Breakthrough! Exciting interim Phase II Data of LP-003 in CSU released by Longbio at AAAAI 2025

SAN DIEGO, March 3, 2025 /PRNewswire/ -- Longbio Pharma (Suzhou) Co., Ltd. (referred to as "Longbio"), a leading biotech company dedicated to developing innovative...

Explore The Infinite: HIKMICRO First Unveils “Digital System” Concept on IWA 2025

HANGZHOU, China, March 2, 2025 /PRNewswire/ -- HIKMICRO, the leading pioneer of technology exploration in the hunting market, unveiled its vision for the future...

JJ Lin’s ‘JJ20 FINAL LAP World Tour’ Presented by Prudential, is Ready to Electrify Hong Kong at Kai Tak Stadium in May

HONG KONG, March 2, 2025 /PRNewswire/ -- A Mandopop superstar JJ Lin kicked off his "JJ20 FINAL LAP World Tour" last December in Singapore....